I'll research this company before writing the profile.
NuVasive, LLC — Company Profile
Company overview. NuVasive, LLC is the San Diego, California–based spine-surgery business formerly known as NuVasive, Inc. It was incorporated on July 21, 1997, and grew into a public company trading on Nasdaq under the ticker NUVA, with net sales above $1 billion and operations in more than 50 countries. On September 1, 2023, Globus Medical, Inc. (NYSE: GMED) completed an all-stock acquisition of NuVasive valued at roughly $3.1 billion (0.75 Globus Class A shares per NuVasive share), and NuVasive became a wholly owned subsidiary of Globus. Delaware records dated February 29, 2024 reflect a conversion of NuVasive, Inc. into a limited liability company, NuVasive, LLC. Pre-acquisition headcount was reported in the low thousands.
Products / services. NuVasive is an operating medical-device company, not an NPE. It designs, manufactures, and sells procedurally integrated systems for minimally invasive spine surgery: lateral and posterior access instruments (e.g., its XLIF/Maxcess-style retractor platform), interbody implants and integrated fixation systems, cervical total disc replacement (Simplify), neuromonitoring hardware and intraoperative monitoring services, biologics for fusion, and the Pulse software/hardware platform. It also markets MAGEC/Precice limb-lengthening devices. Product lines named in litigation include Base, Brigade, CoRoent, MOD-EX PL/XLIF, Simplify, TLX, and X-CORE.
Patent-litigation posture. NuVasive appears in the tracked data as a pure defendant: 0 cases as plaintiff, 1 as defendant. This is the profile of an operating company defending against patent-assertion claims rather than an active two-way litigant. The lone tracked suit sits in the U.S. District Court for the District of Delaware, a common patent venue, not the Eastern District of Texas.
Notable case. Moskowitz Family LLC v. NuVasive, LLC et al. (D. Del., filed June 6, 2025) was brought by Moskowitz Family LLC, a Rockville, Maryland licensing entity formed by neurosurgeon Dr. Mosheh Moskowitz that states it owns nearly 100 U.S. patents on minimally invasive spinal fixation and was "created to develop… and protect and license" that IP. The complaint asserts multiple patents (including the '363, '293, and '743 patents) against the NuVasive product families above. NuVasive answered and counterclaimed in August 2025. The case is proceeding before Judge William C. Bryson, with a jury trial set for February 2027.